Editorial board

Dr Katinka van de Ven


Katinka van de Ven, Ph.D., holds a M.Sc. in Psychology and a M.A. in Criminology from the Utrecht University. Her Ph.D. focused on the production, distribution and use of anabolic-androgenic steroids and other image enhancing drugs in Belgium and the Netherlands. For this research, she received the Research Prize Award from the University of Kent in 2016. She currently works as a Research Fellow at the National Drug and Alcohol Research Centre (NDARC) at the University of New South Wales. In addition, she in collaboration with her colleague Kyle Mulrooney created the Human Enhancement Drug Network (www.humanenhancementdrugs.com). The goal of the network and website is to provide evidence-based information, to share knowledge and experience, to provide harm reduction and human enhancement drug (HED) education, and to collaborate in this growing field of HEDs. Her research interests are in the field of HEDs, drug use and supply, harm reduction, drug policy, anti-doping, health, nutrition and sports. Outside of her academic career, Van de Ven is also highly active in Crossfit, both as a trainer and coach, and bodybuilding, and in her spare time advises clients on nutrition and supplements.

Dr Kyle Mulrooney

BW Kyle-Mulrooney (1) 2

Dr. Kyle Mulrooney holds a Ph.D. in Cultural and Global Criminology from the University of Kent and Universität Hamburg, an MA in the Sociology of Law from the International Institute for the Sociology of Law and a BA (Honours) in Criminology and Justice from the University of Ontario Institute of Technology. Kyle is a Lecturer in Criminology at the University of New England. His primary research area is the Sociology of punishment. Kyle’s current research project examines how Canada’s political culture is the cause for the jurisidctions resistance against penal populism, a governing strategy that achieved much politcal success and penal impact elsewhere. Following this research on the politics of punishment, he has taken an interest in the politics and policies surrounding the consumption and regulation of human enhancement drugs. His research in this field aims to explore the use of human enhancement drugs in society and to identify policy strategies which attend to this issue from a socio-cultural and public health perspective. Together with colleagues, Kyle is currently working on an article which asks whether the ‘dark-side’ of steroids has been overstated, as well as an edited collection entitled Human Enhancement Drugs with Routledge due out in 2019.

Anders Schmidt Vinther, MSc.

Anders Profile

Anders Schmidt Vinther currently works as a PhD student at the Department of Public Health at Aarhus University in Denmark. He holds a MSc in Sport Science, and his research focuses on muscle building drug use and prevention in gyms and fitness centres. He has previously been in charge of a municipal doping prevention project, Aalborg Antidoping, which aimed at preventing recreational athletes’ use of doping substances, and after this he worked with drug, alcohol, and tobacco prevention as a public health consultant employed at Aalborg Municipality. From his many years of involvement in strength training environments, in particular bodybuilding and powerlifting communities, he has an academic as well as a personal interest in the topic of human enhancement.

Dr April Henning

Henning BW pic

April Henning, Ph.D., is Scholar in Residence at Brooklyn College in the U.S. Her work focuses on the impacts of anti-doping policies on athlete health, with a special interest in amateur sport. Her doctoral work focused on the experience of runners, and has since collaborated on research on cyclists and is working on projects looking at cross-national and cross-sport populations. The National Institute on Drug Abuse (NIDA) supported her post-doctoral work at NDRI. She has received additional research funding from the International Association of Athletics Federations (IAAF) and the World Anti-Doping Agency (WADA). April is a member of USA Cycling’s Committee on Anti-Doping.